Obserwuj
Charlie Massie
Charlie Massie
Group Leader, Early Detection Programme, CRUK Cambridge Centre
Zweryfikowany adres z cam.ac.uk - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Liquid biopsies come of age: towards implementation of circulating tumour DNA
JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ...
Nature Reviews Cancer 17 (4), 223-238, 2017
21832017
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
J Nangalia, CE Massie, EJ Baxter, FL Nice, G Gundem, DC Wedge, ...
New England Journal of Medicine 369 (25), 2391-2405, 2013
21182013
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1662*2020
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
14202011
Enhanced detection of circulating tumor DNA by fragment size analysis
F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ...
Science translational medicine 10 (466), eaat4921, 2018
8142018
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
6982011
Effect of mutation order on myeloproliferative neoplasms
CA Ortmann, DG Kent, J Nangalia, Y Silber, DC Wedge, J Grinfeld, ...
New England Journal of Medicine 372 (7), 601-612, 2015
5902015
Classification and personalized prognosis in myeloproliferative neoplasms
J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ...
New England Journal of Medicine 379 (15), 1416-1430, 2018
5572018
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ...
Nature genetics 47 (4), 367-372, 2015
4692015
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
NL Sharma, CE Massie, A Ramos-Montoya, V Zecchini, HE Scott, ...
Cancer cell 23 (1), 35-47, 2013
4322013
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ...
elife 3, e02935, 2014
3922014
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
CE Massie, B Adryan, NL Barbosa‐Morais, AG Lynch, MG Tran, DE Neal, ...
EMBO reports 8 (9), 871-878, 2007
3022007
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
CS Ross-Innes, R Stark, KA Holmes, D Schmidt, C Spyrou, R Russell, ...
Genes & development 24 (2), 171-182, 2010
2842010
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
M Asim, F Tarish, HI Zecchini, K Sanjiv, E Gelali, CE Massie, A Baridi, ...
Nature communications 8 (1), 374, 2017
2512017
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel
AA Ahmed, AD Mills, AEK Ibrahim, J Temple, C Blenkiron, M Vias, ...
Cancer cell 12 (6), 514-527, 2007
2452007
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
GC Sellar, KP Watt, GJ Rabiasz, EA Stronach, L Li, EP Miller, CE Massie, ...
Nature genetics 34 (3), 337-343, 2003
2362003
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ...
Nature genetics 50 (5), 682-692, 2018
2322018
Inactivating CUX1 mutations promote tumorigenesis
CC Wong, I Martincorena, AG Rust, M Rashid, C Alifrangis, ...
Nature genetics 46 (1), 33-38, 2014
1592014
The importance of DNA methylation in prostate cancer development
CE Massie, IG Mills, AG Lynch
The Journal of steroid biochemistry and molecular biology 166, 1-15, 2017
1512017
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
N Pertega‐Gomes, S Felisbino, CE Massie, JR Vizcaino, R Coelho, ...
The Journal of pathology 236 (4), 517-530, 2015
1472015
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20